Acuta Capital Partners, LLC Essa Pharma Inc. Transaction History

Acuta Capital Partners, LLC

  • $98.8 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$7.76 - $29.37 $1.81 Million - $6.84 Million
-232,896 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$24.17 - $34.28 $1.31 Million - $1.85 Million
-54,104 Reduced 18.85%
232,896 $6.65 Million
Q1 2021

May 17, 2021
BUY
$11.61 - $32.08 $3.33 Million - $9.21 Million
287,000 New
287,000 $8.34 Million

Others Institutions Holding EPIX

# of Institutions
38
Shares Held
39.3M
Call Options Held
15.8K
Put Options Held
21K
View Full List

About ESSA Pharma Inc.

EPIX Quotes by TradingView
  • Ticker EPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,073,100
  • Market Cap $74M
  • Description
  • ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...
More about EPIX
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email